NFDI4DS | UHH-SEMS - Publication Details

Benjamin C Cowie

ORCID: 0000-0002-7087-5895

Publications

Citations

Views

---

Saved

---

About

Contact & Profiles

A5043086835

Research Areas

Hepatitis B Virus Studies
Hepatitis C virus research
Liver Disease Diagnosis and Treatment
Hepatitis Viruses Studies and Epidemiology
COVID-19 Clinical Research Studies
Health disparities and outcomes
Long-Term Effects of COVID-19
SARS-CoV-2 and COVID-19 Research
Global Public Health Policies and Epidemiology
Global Maternal and Child Health
Vaccine Coverage and Hesitancy
Influenza Virus Research Studies
COVID-19 epidemiological studies
COVID-19 and healthcare impacts
Climate Change and Health Impacts
HIV, Drug Use, Sexual Risk
HIV/AIDS Research and Interventions
Data-Driven Disease Surveillance
Global Health Care Issues
Healthcare Systems and Reforms
Liver Disease and Transplantation
HIV/AIDS Impact and Responses
Hepatocellular Carcinoma Treatment and Prognosis
Colorectal Cancer Screening and Detection
Global Cancer Incidence and Screening

The University of Melbourne
2016-2025

Victorian Infectious Diseases Reference Laboratory
2014-2024

The Royal Melbourne Hospital
2015-2024

Peter Doherty Institute
2015-2024

Government of Western Australia Department of Health
2015-2024

Government of Victoria
2019-2024

Australian Government
2024

Breast Cancer Network Australia
2024

Australian Centre for HIV and Hepatitis Virology Research
2021-2023

Institute for Health Metrics and Evaluation
2018-2022

Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010

OPENALEX - Publications

Rafael Lozano Mohsen Naghavi Kyle J Foreman Stephen S Lim Kenji Shibuya and 95 more

10.1016/s0140-6736(12)61728-0 article EN The Lancet 2012-12-01

A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010

OPENALEX - Publications

Stephen S Lim Theo Vos Abraham D Flaxman Goodarz Danaei Kenji Shibuya and 95 more

10.1016/s0140-6736(12)61766-8 article EN The Lancet 2012-12-01

Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010

OPENALEX - Publications

Christopher J L Murray Theo Vos Rafael Lozano Mohsen Naghavi Abraham D Flaxman and 95 more

10.1016/s0140-6736(12)61689-4 article EN The Lancet 2012-12-01

Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010

OPENALEX - Publications

Theo Vos Abraham D Flaxman Mohsen Naghavi Rafael Lozano Catherine Michaud and 95 more

10.1016/s0140-6736(12)61729-2 article EN The Lancet 2012-12-01

Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015

OPENALEX - Publications

Christina Fitzmaurice Christine A. Allen Ryan M Barber Lars Barregård Zulfiqar A Bhutta and 95 more

Cancer is the second leading cause of death worldwide. Current estimates on burden cancer are needed for control planning.

10.1001/jamaoncol.2016.5688 article EN JAMA Oncology 2016-12-05

The Global Burden of Cancer 2013

OPENALEX - Publications

Christina Fitzmaurice Daniel Dicker Amanda Pain Hannah Hamavid Maziar Moradi‐Lakeh and 95 more

IMPORTANCECancer is among the leading causes of death worldwide.Current estimates cancer burden in individual countries and regions are necessary to inform local control strategies.OBJECTIVE To estimate mortality, incidence, years lived with disability (YLDs), life lost (YLLs), disability-adjusted life-years (DALYs) for 28 cancers 188 by sex from 1990 2013. EVIDENCE REVIEWThe general methodology Global Burden Disease (GBD) 2013 study was used.Cancer registries were source incidence data as...

10.1001/jamaoncol.2015.0735 article EN JAMA Oncology 2015-05-28

The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level

OPENALEX - Publications

Tomi Akinyemiju Semaw Ferede Abera Muktar Beshir Ahmed Noore Alam Mulubirhan Assefa Alemayohu and 78 more

<h3>Importance</h3> Liver cancer is among the leading causes of deaths globally. The most common for liver include hepatitis B virus (HBV) and C (HCV) infection alcohol use. <h3>Objective</h3> To report results Global Burden Disease (GBD) 2015 study on primary incidence, mortality, disability-adjusted life-years (DALYs) 195 countries or territories from 1990 to 2015, present global, regional, national estimates burden attributable HBV, HCV, alcohol, an "other" group that encompasses residual...

10.1001/jamaoncol.2017.3055 article EN JAMA Oncology 2017-10-05

The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017

OPENALEX - Publications

Sadaf G Sepanlou Saeid Safiri Catherine Bisignano Kevin S Ikuta Shahin Merat and 95 more

<h2>Summary</h2><h3>Background</h3> Cirrhosis and other chronic liver diseases (collectively referred to as cirrhosis in this paper) are a major cause of morbidity mortality globally, although the burden underlying causes differ across locations demographic groups. We report on results from Global Burden Diseases, Injuries, Risk Factors Study (GBD) 2017 its trends since 1990, by cause, sex, age, for 195 countries territories. <h3>Methods</h3> used data vital registrations, registration...

10.1016/s2468-1253(19)30349-8 article EN cc-by The Lancet. Gastroenterology & hepatology 2020-01-22

Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013

OPENALEX - Publications

Christopher J L Murray Katrina F Ortblad Caterina Guinovart Stephen S Lim Timothy M Wolock and 95 more

10.1016/s0140-6736(14)60844-8 article EN The Lancet 2014-07-22

Global, regional, and national burden of hepatitis B, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019

OPENALEX - Publications

Brittney S Sheena Lindsey Hiebert Hannah Han Helen Ippolito Mohsen Abbasi‐Kangevari and 95 more

Combating viral hepatitis is part of the UN Sustainable Development Goals (SDGs), and WHO has put forth B elimination targets in its Global Health Sector Strategy on Viral Hepatitis (WHO-GHSS) Interim Guidance for Country Validation Elimination (WHO Guidance). We estimated global, regional, national prevalence virus (HBV), as well mortality disability-adjusted life-years (DALYs) due to HBV, Burden Diseases, Injuries, Risk Factors Study (GBD) 2019. This included estimates 194 member states,...

10.1016/s2468-1253(22)00124-8 article EN cc-by The Lancet. Gastroenterology & hepatology 2022-06-21

Estimating the burden of disease attributable to injecting drug use as a risk factor for HIV, hepatitis C, and hepatitis B: findings from the Global Burden of Disease Study 2013

OPENALEX - Publications

Louisa Degenhardt Fiona J Charlson Jeffrey D Stanaway Sarah Larney Lily Alexander and 6 more

Previous estimates of the burden HIV, hepatitis B virus (HBV), and C (HCV) among people who inject drugs have not included attributable to consequences past injecting. We aimed provide these as part Global Burden Disease (GBD) Study 2013.We modelled HBV HCV (including cirrhosis liver cancer burden) HIV at country, regional, global level. extracted United Nations data on proportion notified cases by transmission route, estimated contribution injecting drug use (IDU) disease a cohort method...

10.1016/s1473-3099(16)30325-5 article EN cc-by-nc-nd The Lancet Infectious Diseases 2016-09-21

Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study

OPENALEX - Publications

Devin Razavi‐Shearer Ivane Gamkrelidze Calvin Q. Pan Jidong Jia Thomas Berg and 95 more

10.1016/s2468-1253(23)00197-8 article EN The Lancet. Gastroenterology & hepatology 2023-07-27

The burden of chronic hepatitis B virus infection in Australia, 2011

OPENALEX - Publications

Jennifer H MacLachlan Nicole Allard Vanessa Towell Benjamin C Cowie

10.1111/1753-6405.12049 article EN Australian and New Zealand Journal of Public Health 2013-03-21

Australian consensus recommendations for the management of hepatitis B

OPENALEX - Publications

John Lubel Simone I. Strasser Alexander J. Thompson Benjamin C Cowie Jennifer H MacLachlan and 7 more

The prevalence of hepatitis B virus (HBV) infection in Australia is nearly 1%. In certain well defined groups the far greater, yet an estimated 27% people living with HBV remain undiagnosed. Appropriate screening improves detection, increases opportunity for treatment, and ultimately reduces significant morbidity mortality associated development liver fibrosis hepatocellular carcinoma (HCC).This statement highlights important aspects management Australia. There have been recent changes...

10.5694/mja2.51430 article EN The Medical Journal of Australia 2022-03-06

Modeling Progress Toward Elimination of Hepatitis B in Australia

OPENALEX - Publications

Karen McCulloch Nicole Romero Jennifer H MacLachlan Nicole Allard Benjamin C Cowie

Background and Aims Chronic hepatitis B (CHB) is a significant global health concern, the most prevalent blood‐borne virus in Australia. World Health Organization (WHO) member states have committed to elimination, with targets diagnose 90% of people living CHB, treat 80% those eligible, reduce attributable deaths by 65% year 2030. Australia has national diagnosed, 20% on treatment, 30% reduction 2022. Approach Results We constructed implemented mathematical model estimate burden CHB...

10.1002/hep.30899 article EN cc-by-nc-nd Hepatology 2019-08-16

Coming Soon ...